NIOSH Publication No. 2005-151:

NIOSH Pocket Guide to Chemical Hazards

September 2005

Benzene

CAS
71-43-2

C6H6

RTECS
CY1400000
Synonyms & Trade Names

Benzol, Phenyl hydride
DOT ID & Guide
1114 / 130

Exposure
Limits

NIOSH REL: Ca TWA 0.1 ppm ST 1 ppm See Appendix A
OSHA PEL: [1910.1028] TWA 1 ppm ST 5 ppm See Appendix F
IDLH
Ca [500 ppm] See: 71432
Conversion
1 ppm = 3.19 mg/m3
Physical Description
Colorless to light-yellow liquid with an aromatic odor. [Note: A solid below 42°F.]
MW: 78.1
BP: 176°F
FRZ: 42°F
Sol: 0.07%
VP: 75 mmHg
IP: 9.24 eV

Sp.Gr: 0.88
Fl.P: 12°F
UEL: 7.8%
LEL: 1.2%

Class IB Flammable Liquid: Fl.P. below 73°F and BP at or above 100°F.
Incompatibilities & Reactivities

Strong oxidizers, many fluorides & perchlorates, nitric acid
Measurement Methods
NIOSH 1500, 1501, 3700, 3800; OSHA 12, 1005
See: NMAM or OSHA Methods
Personal Protection & Sanitation
(See protection)
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: When contaminated
Remove: When wet (flammable)
Change: No recommendation
Provide: Eyewash, Quick drench
First Aid
(See procedures)
Eye: Irrigate immediately
Skin: Soap wash immediately
Breathing: Respiratory support
Swallow: Medical attention immediately
Respirator Recommendations
(See Appendix E) NIOSH
At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration:
(APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode
(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus
Escape:
(APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus
Important additional information about respirator selection
Exposure Routes
inhalation, skin absorption, ingestion, skin and/or eye contact
Symptoms
Irritation eyes, skin, nose, respiratory system; dizziness; headache, nausea, staggered gait; anorexia, lassitude (weakness, exhaustion); dermatitis; bone marrow depression; [potential occupational carcinogen]
Target Organs
Eyes, skin, respiratory system, blood, central nervous system, bone marrow

Cancer Site
[leukemia]
See also: INTRODUCTION   See ICSC CARD: 0015   See MEDICAL TESTS: 0022